+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 8Years - 18Years
All Genders
ID07802340

Randomized Study Comparing Asiaticoside and Calcium Hydroxide as Intracanal Medications for Revascularization in Immature Permanent Teeth with Pulp Necrosis

Led by Mansoura University · Updated on 2026-09-23

20

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of Asiaticoside as an intracanal medication compared to the commonly used calcium hydroxide in the revascularization process for immature permanent teeth with pulp necrosis. This clinical trial aims to assess how these treatments affect root development and healing in young patients with open apex teeth. Participants will receive intracanal medication for three weeks as part of the revascularization procedure. The study compares two groups one treated with Asiaticoside and the other with calcium hydroxide. This randomized, double-blind trial will monitor the effects on root length, dentinal wall thickness, and periapical bone formation over a 12-month period. During the study, participants will be regularly evaluated to measure changes in their tooth structure through imaging and clinical assessments. The primary outcomes focus on increases in root length, dentinal wall thickness, and bone healing around the root area. The total study duration includes follow-up assessments lasting up to 12 months after treatment to monitor progress and safety.

CONDITIONS

Brief Title

Efficiency of Asiaticoside as Intracanal Medication in Revascularization Process

Research Team

M

Maha Baher Hassan

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here